Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
XtalPi HoldingsFRA:V0I +6.54%22 Return-on-Tangible-Equity is 1.03% as of Dec. 2025, which is 46% below its 10-year median of 1.91. GuruFocus rates FRA:V0I with a GF Score™ of 22/100. The stock has 7 warning signs investors should review. Among 580 Healthcare Providers & Services companies, XtalPi Holdings ranks worse than 70.69% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. XtalPi Holdings's annualized net income for the quarter that ended in Dec. 2025 was €9.93 Mil. XtalPi Holdings's average shareholder tangible equity for the quarter that ended in Dec. 2025 was €963.10 Mil. Therefore, XtalPi Holdings's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 1.03%.
The historical rank and industry rank for XtalPi Holdings's Return-on-Tangible-Equity or its related term are showing as below:
FRA:V0I'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 1.87 Med: 1.91 Max: 1.91
Current: 1.87
During the past 5 years, XtalPi Holdings's highest Return-on-Tangible-Equity was 1.91%. The lowest was 1.87%. And the median was 1.91%.
FRA:V0I's Return-on-Tangible-Equity is ranked worse than 70.69% of 580
companies
in the Healthcare Providers & Services industry
Industry Median: 10.085
vs FRA:V0I: 1.87
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
XtalPi Holdings Return-on-Tangible-Equity Related Terms
XtalPi Holdings Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for XtalPi Holdings's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:V0I vs VEEV, BTSG, TEM: Return-on-Tangible-Equity Comparison
For the Health Information Services subindustry, XtalPi Holdings's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
XtalPi Holdings Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, XtalPi Holdings's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where XtalPi Holdings's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 1.03% mean?
XtalPi Holdings (FRA:V0I) has a Return-on-Tangible-Equity of 1.03% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on XtalPi Holdings and its competitors. This is 46% below median its historical median of 1.91. Over the past decade, XtalPi Holdings' Return-on-Tangible-Equity has ranged from 1.87 to 1.91. According to the industry distribution chart, XtalPi Holdings ranks #410 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 70.7%.
Is XtalPi Holdings' Return-on-Tangible-Equity too high?
XtalPi Holdings' current Return-on-Tangible-Equity of 1.03% is 46% below median its 10-year median of 1.91. Over the past 10 years, this metric has ranged from a low of 1.87 to a high of 1.91. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.09. XtalPi Holdings' value of 1.03% is 89.8% below this industry median. Based on the distribution chart, XtalPi Holdings ranks #410 out of 580 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, XtalPi Holdings has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does XtalPi Holdings' Return-on-Tangible-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, XtalPi Holdings ranks #410 out of 580 companies for Return-on-Tangible-Equity. This places XtalPi Holdings in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.09. XtalPi Holdings' value of 1.03% is 89.8% below this benchmark. Historically, XtalPi Holdings' own Return-on-Tangible-Equity has ranged from 1.87 to 1.91 over the past decade. While the company's 10-year median is 1.91 vs. the industry median of 10.09, XtalPi Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.09, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. XtalPi Holdings's current Return-on-Tangible-Equity of 1.03% is 89.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on XtalPi Holdings and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. XtalPi Holdings's current Return-on-Tangible-Equity is 1.03%, which is 46% below median its own 10-year median of 1.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is XtalPi Holdings stock overvalued right now?
XtalPi Holdings (FRA:V0I) has a current Return-on-Tangible-Equity of 1.03%. The current Return-on-Tangible-Equity is 1.03%, which is 46% below median its 10-year median of 1.91 and 89.8% below the Healthcare Providers & Services industry median of 10.09. XtalPi Holdings' overall GF Score™ is 22/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For XtalPi Holdings (FRA:V0I), the current Return-on-Tangible-Equity is 1.03% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
XtalPi Holdings Ltd is a research platform company powered by artificial intelligence (AI) and robotics. It is dedicated to driving intelligent and digital transformation in the life sciences and materials sciences sectors. The company combines quantum physics, AI, cloud computing, and large-scale robotics to provide research & development solutions, services, and products for pharmaceuticals, biotechnology, renewable energy, and materials industries globally. The company has a single segment that is intelligent robotics solutions and drug discovery solutions (including one-stop drug discovery solutions). The firm generates the majority of its revenue from Drug discovery solutions, and a smaller portion of revenue is derived from AI for Science intelligent solutions.
22GF Score
Get the complete analysis for FRA:V0I
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:V0I has been successfully added to your 
